Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
about
Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.Clinical utility of therapeutic drug monitoring in biological disease modifying anti-rheumatic drug treatment of rheumatic disorders: a systematic narrative review.TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database.Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky.Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy.Gender Is a Risk Factor for Annual Decline in Estimated Glomerular Filtration Rate in Patients Treated with Biological DMARDs in Rheumatoid Arthritis and Ankylosing Spondylitis: a Retrospective Observational Study
P2860
Q37612248-0A4A8B13-5098-4214-A063-3AB9266605D8Q39420995-C7D42E16-B338-4BEE-957D-AB85C2CE0159Q47677081-B86B41C6-7BD1-4977-9FB8-078C4C675551Q47705810-A49C4862-9452-47EC-819A-03EECE2F6085Q54986979-36522371-9CA5-4FB1-A61C-C8D292CEBA77Q55073579-1928F002-4826-4FC2-B48A-AAE31EBCC43EQ57985170-2BF81B02-0574-4E0E-9172-15A1FDB503A8
P2860
Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Efficacy and safety of biologi ...... nt of axial spondyloarthritis.
@en
type
label
Efficacy and safety of biologi ...... nt of axial spondyloarthritis.
@en
prefLabel
Efficacy and safety of biologi ...... nt of axial spondyloarthritis.
@en
P2093
P2860
P50
P1433
P1476
Efficacy and safety of biologi ...... nt of axial spondyloarthritis.
@en
P2093
Alexandre Sepriano
Andrea Regel
Filip Van den Bosch
Jürgen Braun
Louise Falzon
Xenofon Baraliakos
P2860
P304
P356
10.1136/RMDOPEN-2016-000396
P577
2017-01-27T00:00:00Z